Cargando…
PPARγ/NF‐κB and TGF‐β1/Smad pathway are involved in the anti‐fibrotic effects of levo‐tetrahydropalmatine on liver fibrosis
Liver fibrosis is a necessary stage in the development of chronic liver diseases to liver cirrhosis. This study aims to investigate the anti‐fibrotic effects of levo‐tetrahydropalmatine (L‐THP) on hepatic fibrosis in mice and cell models and its underlying mechanisms. Two mouse hepatic fibrosis mode...
Autores principales: | Yu, Qiang, Cheng, Ping, Wu, Jianye, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875896/ https://www.ncbi.nlm.nih.gov/pubmed/33438347 http://dx.doi.org/10.1111/jcmm.16267 |
Ejemplares similares
-
Levo-tetrahydropalmatine attenuates oxaliplatin-induced mechanical hyperalgesia in mice
por: Guo, Zhenggang, et al.
Publicado: (2014) -
Preparation of the Levo-Tetrahydropalmatine Liposome Gel and Its Transdermal Study
por: Zhang, Guizhen, et al.
Publicado: (2023) -
The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are via TRAF6/JNK Signaling
por: Yu, Qiang, et al.
Publicado: (2018) -
Levo-Tetrahydropalmatine Attenuates Bone Cancer Pain by Inhibiting Microglial Cells Activation
por: Zhang, Mao-yin, et al.
Publicado: (2015) -
TGF‐β/Smad and JAK/STAT pathways are involved in the anti‐fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis
por: Xu, Shizan, et al.
Publicado: (2020)